drugset
drugset / Trial / NCT01124006

A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Degeneration

NCT01124006 ↗

Phase 2 Completed 24 enrolled DePuy Spine
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to show the safety and tolerability of Intradiscal rhGDF-5 in subjects with early lumbar disc degeneration

Timeline

Start
2010-01
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject RADOTERMIN Protein / enzyme biologic — Other

Indications

intervertebral disk degenerative disorder